Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol
about
Cardiac resynchronization therapy in heart failure patients with less severe left ventricular dysfunctionA Review of the External Validity of Clinical Trials with Beta-Blockers in Heart FailureCarvedilol versus other beta-blockers in heart failure.Relative contribution of resting haemodynamic profile and lung function to exercise tolerance in male patients with chronic heart failure.Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study.Carvedilol: use in chronic heart failure.Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary diseasePrognostic value and diagnostic potential of cardiopulmonary exercise testing in patients with chronic heart failure.Glomerular filtration rate affects interpretation of pulmonary function test in a Korean general population: results from the Korea National Health and Nutrition Examination Survey 2010 to 2012.Excess ventilation during exercise and prognosis in chronic heart failure.β-Blockers in heart failure: benefits of β-blockers according to varying male proportions of study patients.Gas exchange consequences of left heart failure.Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach.Exercise-induced changes in exhaled nitric oxide in heart failure.The effects of long-term beta-blockade on the ventilatory responses to exercise in chronic heart failure.Carvedilol reduces exercise-induced hyperventilation: A benefit in normoxia and a problem with hypoxia.The effect of diuresis on extravascular lung water and pulmonary function in acute decompensated heart failure.Combining the ventilatory response to exercise and peak oxygen consumption is no better than peak oxygen consumption alone in predicting mortality in chronic heart failure.
P2860
Q27002918-843763F7-B51E-4635-9B63-3CEC4366D883Q28068618-BC302F65-0ED0-496C-91AB-157FD177728EQ34232069-DA5CB96B-3824-4A2A-B0CF-EF83D90710BEQ35378226-24BAFDEA-06D7-48AE-BF3F-72CAAAACAF2CQ35582518-4E79BD91-B9C9-424D-98DF-A2745C364BBDQ36691623-1420A1F1-9BC6-4794-B1EF-325A7C94913DQ37047304-D0166F37-BFAD-448D-BEB1-1AE451CE62A4Q37078627-3FBAF034-E9C6-497C-AD3A-D9303B51E2A1Q37392456-94F31281-A794-44EE-A433-84ECBC855578Q37831731-6A7D066F-B2CC-4EE2-A22B-16E062B05505Q38001302-3BD18538-3F45-42CF-B3C3-79B766170706Q38112052-790ABC6F-138D-4543-AAD3-4B4ED0FA00F1Q41845098-BF51EA38-B020-4AE2-BD32-8FECBF69BC41Q45011954-FE9E0A90-811A-4FC7-8CE7-D4ACB50573FEQ46514958-A2D17556-A2E1-4D3F-AB47-DE0EE6D65606Q46988303-73DBBB78-675E-4554-BBC7-47B7C43DD321Q47711807-B513AC20-8E3B-4397-8444-0CB528498E3AQ52852412-370B2FDD-1D19-44D4-9D05-AC37224A6A96
P2860
Pulmonary function, cardiac function, and exercise capacity in a follow-up of patients with congestive heart failure treated with carvedilol
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pulmonary function, cardiac fu ...... ailure treated with carvedilol
@ast
Pulmonary function, cardiac fu ...... ailure treated with carvedilol
@en
Pulmonary function, cardiac fu ...... ailure treated with carvedilol
@nl
type
label
Pulmonary function, cardiac fu ...... ailure treated with carvedilol
@ast
Pulmonary function, cardiac fu ...... ailure treated with carvedilol
@en
Pulmonary function, cardiac fu ...... ailure treated with carvedilol
@nl
prefLabel
Pulmonary function, cardiac fu ...... ailure treated with carvedilol
@ast
Pulmonary function, cardiac fu ...... ailure treated with carvedilol
@en
Pulmonary function, cardiac fu ...... ailure treated with carvedilol
@nl
P2093
P3181
P1476
Pulmonary function, cardiac fu ...... ailure treated with carvedilol
@en
P2093
P3181
P356
10.1016/S0002-8703(99)70148-1
P407
P433
P577
1999-09-01T00:00:00Z